Table 1 |
|||
|
Characteristics of study participants |
|||
|
Characteristic |
Sulphadoxine-pyrimethamine n = 535 |
Placebo n = 535 |
p† |
|
|
|||
|
Sex, no. |
|||
|
Male |
264 (49.3%) |
272 (50.8%) |
0.63 |
|
Female |
271 (50.7%) |
263 (49.2%) |
|
|
Age in weeks at recruitment, mean (SD) |
|||
|
Age at IPTi-1* |
12.3 (± 1.7) |
12.3 (± 1.6) |
0.85 |
|
Use of bednets, no. |
|||
|
Yes |
210 (39.3%) |
201 (37.6%) |
|
|
No |
261 (48.8%) |
263 (49.2%) |
0.75 |
|
Missing data |
64 (12.0%) |
71 (13.3%) |
|
|
P. falciparum parasitaemia at recruitment, no. |
|||
|
Positive |
72 (13.5%) |
86 (16.1%) |
|
|
Negative |
463 (86.5%) |
448 (83.8%) |
0.29 |
|
Missing data |
0 (0.0%) |
1 (0.2%) |
|
|
|
|||
|
SD, standard deviation. * Age at IPTi-1 is equal to age at time of recruitment. † By Wilcoxon or χ2 test, none of the parameters in both study arms was significantly different. |
|||
|
Kobbe et al. Malaria Journal 2007 6:163 doi:10.1186/1475-2875-6-163 |
|||
